163 related articles for article (PubMed ID: 34460321)
21. DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies.
D'Argenio V; Frisso G; Precone V; Boccia A; Fienga A; Pacileo G; Limongelli G; Paolella G; Calabrò R; Salvatore F
J Mol Diagn; 2014 Jan; 16(1):32-44. PubMed ID: 24183960
[TBL] [Abstract][Full Text] [Related]
22.
Dias GM; Lamounier Júnior A; Seifert M; Barájas-Martinez H; Barr D; Sternick EB; Medina-Acosta E; Campos de Carvalho AC; Cruz Filho FES
Circ Genom Precis Med; 2021 Oct; 14(5):e003476. PubMed ID: 34555931
[No Abstract] [Full Text] [Related]
23. Hypertrophic cardiomyopathy: a practical approach to guideline directed management.
Ommen SR; Semsarian C
Lancet; 2021 Dec; 398(10316):2102-2108. PubMed ID: 34600606
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy.
Wang B; Wang J; Wang LF; Yang F; Xu L; Li WX; He Y; Zuo L; Yang QL; Shao H; Hu D; Liu LW
Mol Med Rep; 2019 Dec; 20(6):5229-5238. PubMed ID: 31638223
[TBL] [Abstract][Full Text] [Related]
25. [Hypertrophic cardiomyopathy: infrequent mutation of the cardiac beta-myosin heavy-chain gene].
Mora R; Merino JL; Peinado R; Olias F; García-Guereta L; del Cerro MJ; Tarín MN; Molano J
Rev Esp Cardiol; 2006 Aug; 59(8):846-9. PubMed ID: 16938236
[TBL] [Abstract][Full Text] [Related]
26. Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation.
Overeem S; Schelhaas HJ; Blijham PJ; Grootscholten MI; ter Laak HJ; Timmermans J; van den Wijngaard A; Zwarts MJ
Neuromuscul Disord; 2007 Jun; 17(6):490-3. PubMed ID: 17383184
[TBL] [Abstract][Full Text] [Related]
27. Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy.
Robyns T; Breckpot J; Nuyens D; Vandenberk B; Corveleyn A; Kuiperi C; Van Aelst L; Van Cleemput J; Willems R
Eur J Med Genet; 2020 Mar; 63(3):103754. PubMed ID: 31513939
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
29. Pooled Genetic Screenings to Identify Likely Pathogenic Variants in Hypertrophic Cardiomyopathy.
Georges A; Chahal CAA
Circ Genom Precis Med; 2024 Apr; 17(2):e004599. PubMed ID: 38497213
[No Abstract] [Full Text] [Related]
30. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
Nag S; Trivedi DV; Sarkar SS; Adhikari AS; Sunitha MS; Sutton S; Ruppel KM; Spudich JA
Nat Struct Mol Biol; 2017 Jun; 24(6):525-533. PubMed ID: 28481356
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound and genetic detection of fetal hypertrophic cardiomyopathy in second trimester of pregnancy.
Soares C; Lourenço C; Nogueira RN; Carrico A
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33408112
[No Abstract] [Full Text] [Related]
32. Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
Blair E; Price SJ; Baty CJ; Ostman-Smith I; Watkins H
J Med Genet; 2001 Jun; 38(6):385-8. PubMed ID: 11424919
[No Abstract] [Full Text] [Related]
33. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
[TBL] [Abstract][Full Text] [Related]
34. [Fabry disease among hypertrophic cardiomyopathy of genetic origin].
Bouvagnet P; Millat G; Rousson R; Gilbert G; Derumeaux G
Rev Med Interne; 2010 Dec; 31 Suppl 2():S233-7. PubMed ID: 21211671
[TBL] [Abstract][Full Text] [Related]
35. Dextrocardia and symmetric hypertrophic cardiomyopathy with multiple mutations of genes encoding the sarcomere proteins.
Fang F; Cui FM; He YM; Yang XJ; Zhao X; Xu HF; Yu CM
Int J Cardiol; 2015; 187():581-4. PubMed ID: 25863306
[No Abstract] [Full Text] [Related]
36. Hypertrophic cardiomyopathy and Anderson-Fabry disease: unravelling septal hypertrophy with T1-mapping CMR.
Edwards NC; Teoh JK; Steeds RP
Eur Heart J; 2014 Jul; 35(28):1896. PubMed ID: 24713641
[No Abstract] [Full Text] [Related]
37. Genetic Association Between Hypoplastic Left Heart Syndrome and Cardiomyopathies.
Theis JL; Hu JJ; Sundsbak RS; Evans JM; Bamlet WR; Qureshi MY; O'Leary PW; Olson TM
Circ Genom Precis Med; 2021 Feb; 14(1):e003126. PubMed ID: 33325730
[TBL] [Abstract][Full Text] [Related]
38. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
[No Abstract] [Full Text] [Related]
39. Clinical Utility of a Phenotype-Enhanced
Mattivi CL; Bos JM; Bagnall RD; Nowak N; Giudicessi JR; Ommen SR; Semsarian C; Ackerman MJ
Circ Genom Precis Med; 2020 Oct; 13(5):453-459. PubMed ID: 32894683
[TBL] [Abstract][Full Text] [Related]
40. Resequencing the whole MYH7 gene (including the intronic, promoter, and 3' UTR sequences) in hypertrophic cardiomyopathy.
Coto E; Reguero JR; Palacín M; Gómez J; Alonso B; Iglesias S; Martín M; Tavira B; Díaz-Molina B; Morales C; Morís C; Rodríguez-Lambert JL; Corao AI; Díaz M; Alvarez V
J Mol Diagn; 2012 Sep; 14(5):518-24. PubMed ID: 22765922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
